| |
| |
|
| Insider
Information: |
Lalande Kevin M. |
| Relationship: |
Director |
| City: |
Austin |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,076 |
|
|
Indirect Shares
|
1,387,709 |
|
|
| Direct
Value |
$2,981 |
|
|
|
Indirect Value
|
$2,417,825 |
|
|
| Total
Shares |
1,388,785 |
|
|
| Total
Value |
$2,420,805 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
22
|
2
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
19
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -22.0%
|
-50.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
LDR Holding Corp |
LDRH |
Director |
2016-07-13 |
0 |
2016-07-13 |
0 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
|
|
0 |
2024-04-02 |
657,263 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Director |
2021-09-08 |
1,076 |
2021-09-08 |
730,446 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MTEM |
Molecular Templates, Inc. |
|
– • • |
2024-04-02 |
4 |
A |
$2.35 |
$411,250 |
I/I |
175,000 |
175,000 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
– • • |
2022-06-15 |
4 |
B |
$0.89 |
$55,180 |
I/I |
62,000 |
222,000 |
2.25 |
% |
|
| MTEM |
Molecular Templates, Inc. |
Director |
– • • |
2022-06-14 |
4 |
B |
$0.87 |
$52,200 |
I/I |
60,000 |
160,000 |
2.25 |
% |
|
| MTEM |
Molecular Templates, Inc. |
Director |
– • • |
2022-06-13 |
4 |
B |
$0.91 |
$91,000 |
I/I |
100,000 |
100,000 |
2.25 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-09-08 |
4 |
B |
$11.21 |
$112,116 |
I/I |
10,000 |
730,446 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-09-07 |
4 |
B |
$11.11 |
$111,139 |
I/I |
10,000 |
720,446 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-09-03 |
4 |
B |
$11.35 |
$91,905 |
I/I |
8,100 |
710,446 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-09-02 |
4 |
B |
$11.23 |
$70,739 |
I/I |
6,300 |
702,346 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-09-01 |
4 |
B |
$10.87 |
$49,892 |
I/I |
4,589 |
696,046 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-31 |
4 |
B |
$10.70 |
$64,181 |
I/I |
6,000 |
691,457 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-30 |
4 |
B |
$10.52 |
$90,738 |
I/I |
8,625 |
685,457 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-27 |
4 |
B |
$10.50 |
$52,282 |
I/I |
4,981 |
677,832 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-26 |
4 |
B |
$10.07 |
$62,430 |
I/I |
6,200 |
672,851 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-25 |
4 |
B |
$9.87 |
$147,078 |
I/I |
14,900 |
666,651 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-24 |
4 |
B |
$9.45 |
$101,871 |
I/I |
10,775 |
651,751 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-23 |
4 |
B |
$9.58 |
$362,150 |
I/I |
37,800 |
640,976 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-20 |
4 |
B |
$8.73 |
$311,638 |
I/I |
35,679 |
603,176 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-19 |
4 |
B |
$8.45 |
$168,970 |
I/I |
20,000 |
567,497 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-18 |
4 |
B |
$8.73 |
$252,009 |
I/I |
28,870 |
547,497 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-17 |
4 |
B |
$8.47 |
$135,446 |
I/I |
16,000 |
518,627 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-16 |
4 |
B |
$7.96 |
$246,717 |
I/I |
31,000 |
502,627 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-13 |
4 |
B |
$7.86 |
$243,744 |
I/I |
31,000 |
471,627 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-08-12 |
4 |
B |
$7.55 |
$233,932 |
I/I |
31,000 |
440,627 |
2.1 |
% |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
367 |
1,076 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
– • • |
2020-09-16 |
4 |
S |
$13.05 |
$6,525,000 |
I/I |
(500,000) |
6,097,298 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
